171 related articles for article (PubMed ID: 28277349)
41. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
42. Update of Perinatal Human Immunodeficiency Virus Type 1 Transmission in France: Zero Transmission for 5482 Mothers on Continuous Antiretroviral Therapy From Conception and With Undetectable Viral Load at Delivery.
Sibiude J; Le Chenadec J; Mandelbrot L; Hoctin A; Dollfus C; Faye A; Bui E; Pannier E; Ghosn J; Garrait V; Avettand-Fenoel V; Frange P; Warszawski J; Tubiana R
Clin Infect Dis; 2023 Feb; 76(3):e590-e598. PubMed ID: 36037040
[TBL] [Abstract][Full Text] [Related]
43. The Effect of HIV-Centered Obstetric Care on Perinatal Outcomes Among a Cohort of Women Living With HIV.
Powell AM; DeVita JM; Ogburu-Ogbonnaya A; Peterson A; Lazenby GB
J Acquir Immune Defic Syndr; 2017 Aug; 75(4):431-438. PubMed ID: 28452911
[TBL] [Abstract][Full Text] [Related]
44. Investigation of mother-to-child transmission of HIV in pregnancy and among HIV-exposed infants accessing care at a PMTCT clinic in southwest Nigeria.
Afolabi AY; Bakarey AS; Kolawole OE; Kola OJ
J Immunoassay Immunochem; 2018; 39(4):403-415. PubMed ID: 30001188
[TBL] [Abstract][Full Text] [Related]
45. Human immunodeficiency virus infection and pregnancy.
Petropoulou H; Stratigos AJ; Katsambas AD
Clin Dermatol; 2006; 24(6):536-42. PubMed ID: 17113971
[TBL] [Abstract][Full Text] [Related]
46. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.
; Andiman W; Bryson Y; de Martino M; Fowler M; Harris D; Hutto C; Korber B; Kovacs A; Landesman S; Lindsay M; Lapointe N; Mandelbrot L; Newell M-L; Peavy H; Read J; Rudin C; Semprini A; Simonds R; Tuomala R
N Engl J Med; 1999 Apr; 340(13):977-87. PubMed ID: 10099139
[TBL] [Abstract][Full Text] [Related]
47. Prevention of perinatal HIV transmission during pregnancy.
McGowan JP; Shah SS
J Antimicrob Chemother; 2000 Nov; 46(5):657-68. PubMed ID: 11062184
[TBL] [Abstract][Full Text] [Related]
48. Mother-to-Child Transmission Outcomes of HIV-Exposed Infants Followed Up in Jos North-Central Nigeria.
Sagay AS; Ebonyi AO; Meloni ST; Musa J; Oguche S; Ekwempu CC; Oyebode T; Ejeliogu E; Imade GE; Agbaji OO; Okonkwo P; Kanki PJ
Curr HIV Res; 2015; 13(3):193-200. PubMed ID: 25986370
[TBL] [Abstract][Full Text] [Related]
49. Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina.
Fiscus SA; Adimora AA; Funk ML; Schoenbach VJ; Tristram D; Lim W; McKinney R; Rupar D; Woods C; Wilfert C
Pediatr Infect Dis J; 2002 Jul; 21(7):664-8. PubMed ID: 12237600
[TBL] [Abstract][Full Text] [Related]
50. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
[TBL] [Abstract][Full Text] [Related]
51. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
[TBL] [Abstract][Full Text] [Related]
52. [Epidemiological characteristics of HIV infected pregnant women and exposed infants in Guangdong province, 2014-2017].
Tang LY; Zhang CB; Gao S; Wang ZQ; Miao HZ; Xia JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1392-1397. PubMed ID: 31838810
[No Abstract] [Full Text] [Related]
53. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.
American Academy of Pediatrics Committee on Pediatric AIDS
Pediatrics; 2008 Nov; 122(5):1127-34. PubMed ID: 18977995
[TBL] [Abstract][Full Text] [Related]
54. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
[TBL] [Abstract][Full Text] [Related]
55. Screening for HIV in pregnant women: systematic review to update the 2005 U.S. Preventive Services Task Force recommendation.
Chou R; Cantor AG; Zakher B; Bougatsos C
Ann Intern Med; 2012 Nov; 157(10):719-28. PubMed ID: 23165663
[TBL] [Abstract][Full Text] [Related]
56. Uptake and performance of prevention of mother-to-child transmission and early infant diagnosis in pregnant HIV-infected women and their exposed infants at seven health centres in Addis Ababa, Ethiopia.
Girma M; Wendaferash R; Shibru H; Berhane Y; Hoelscher M; Kroidl A
Trop Med Int Health; 2017 Jun; 22(6):765-775. PubMed ID: 28407452
[TBL] [Abstract][Full Text] [Related]
57. [Mode of delivery of HIV-infected women: a retrospective study of 358 pregnancies followed in the same hospital between 2000 and 2004].
Rodrigues A; Faucher P; Batallan A; Allal L; Legac S; Matheron S; Madelenat P
Gynecol Obstet Fertil; 2006 Apr; 34(4):304-11. PubMed ID: 16574463
[TBL] [Abstract][Full Text] [Related]
58. Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Curry SJ; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Jun; 321(23):2326-2336. PubMed ID: 31184701
[TBL] [Abstract][Full Text] [Related]
59. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M;
Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307
[TBL] [Abstract][Full Text] [Related]
60. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
